Navigation Links
New Medication May Decrease The Frequency Of Angina Attacks

Nearly 7 million patients suffering from chronic angina report limitations of their work and other activities // two to three times more frequently than the general population. Also, 26 percent of patients still experience angina attacks despite current treatments, such as myocardial revascularization -- a surgery that helps restore blood flow to the heart and is done largely to prevent angina -- and antianginal drugs.

A new treatment may reduce the frequency of angina attacks and help chronic chest pains sufferers exercise longer, according to new research. Researchers say when the drug ranolazine is taken with other antianginal medications, it improves the total exercise time of patients with symptoms of chronic angina.

Ranolazine is currently under review by the FDA. For this study, more than 800 patients with symptomatic chronic angina were randomly assigned to receive a placebo or one or two doses of ranolazine. Patients received either placebos twice a day or 750 mg or 1000 mg of ranolazine. Then, they were monitored as they exercised on a treadmill 12 hours after receiving the medication (when it was at the lowest levels in the bloodstream) and four hours after receiving it (when there were the highest levels of the drug in the bloodstream).

Researchers found that when added to a standard dose of frequently prescribed antianginal drugs, ranolazine can reduce both the angina frequency and nitroglycerin consumption. When compared to the placebo results, the decrease in angina attacks were slightly less than one per week for those in the 750 mg group and somewhat more than one per week in the 1,000 mg group. They also found exercise duration increased by nearly two minutes for those in the ranolazine therapy group compared with 90 seconds for those taking placebos. Specialists say, the availability of another effective and apparently safe antianginal medication is “particularly important” for angina patients who are not candidates
'"/>




Page: 1 2

Related medicine news :

1. What happens when Medications go wrong?
2. Medications to Prevent Relapse to Cocaine Use
3. More Elderly Take Inappropriate and Harmful Medications
4. Medications for depression
5. Medications linked to xerostomia and caries
6. Medication recuperates fat distribution in diabetes
7. Pharmacist’s Role in Medication Error
8. The Downside of Asthma Medication
9. Reducing Medication Errors
10. Oral Medication Effective In Combating Eye Infection
11. Common Medication Errors in Children

Post Your Comments:
(Date:12/2/2009)...swire-USNewswire/ -- The American Association of P...pin Regional Poison Center in Minneapolis, Minneso...r milestone for the center. The designation by th... among 58 accredited poison centers in the United ...complishment. It means we have met the national st...
(Date:12/2/2009)...swire-USNewswire/ -- In response to a press confe... ," an initiative from the U.S. Anti-Doping Agen...r Responsible Nutrition (CRN), the leading trade a...ustry, issued the following statement: ,, Sta..., "We share the concerns of Travis Tygart (USAD...
(Date:12/2/2009)...ses, study finds , , WEDNESDAY, Dec. 2 (...al rates for advanced lung cancer patients in the ...has found. , Researchers analyzed data on more ...mall cell lung cancer (NSCLC) between 1990 and 200...l Cancer Institute,s Surveillance, Epidemiology an...
(Date:12/2/2009)... unclear, researchers say , , WEDNESDAY,...that enzyme replacement therapy can make a major d...e, a rare illness that affects the kidneys, heart ...o the lack of an enzyme that helps metabolic pathw...boosts the risk for a stroke, heart attack and kid...
(Date:12/2/2009)... Researchers from aroun...ancer research at the annual American Society of H... 4-8, 2009. ,, Throughout the ASH conference, ... including Chief Medical Officer Barton Kamen, M.D...s Hildy Dillon, and Vice President, Research Commu...
Breaking Medicine News(10 mins):Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Gains Made in Lung Cancer Survival 2
...Byrd Alzheimer,s Institute Shows Cognitive Activit...Against Memory Loss, TAMPA, Fla., Sept. 12 New r...lifelong activities, only a high level of,mental o...Byrd Institute researchers raised Alzheimer,s mice...
...ad to new drug to treat manic phase of the illness...thDay News) -- The breast cancer drug tamoxifen he...nd works faster than many standard medications use...e this long period before they start to work," exp...
.... 12, 2007 Rice University chemists have discover...ancer drug paclitaxel onto tiny gold spheres. The ...iving cell that literally bristles with the drug. ...e most effective anti-cancer drugs, and many resea...
... Sept. 12 A new, free white paper,details how OSF... has,substantially reduced lift injuries while boo...w lift team department that provides patient trans... Portal, (http://www.safeliftingportal.com ), a pr...
...developed psoriasis at the age of 5; as a teenager...red 70 percent of her body.,Today, her curse is he...l,Psoriasis Foundation, PORTLAND, Ore., Sept. 12 ...y, Sept.,29, at Mission Bay Park. The event featur...
...pt. 12 Psychemedics,Corporation (Amex: PMD ) was...alent Officer, an innovative new book sponsored by...t issues and the growing imperative for,HR leaders...ive approaches to leading,and managing human capit...
Other Medicine News:Health News:Cognitive Activities Protect Against Alzheimer's -- Social and Physical Activities Not Enough 2Health News:Tamoxifen Helps Treat Bipolar Disorder 2Health News:Tamoxifen Helps Treat Bipolar Disorder 3Health News:Taxol bristle ball: a wrench in the works for cancer 2Health News:New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction 2Health News:America's Next Top Model Steps up for Psoriasis Awareness 2Health News:Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book 2Health News:Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book 3
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Hemoglobin A1c M...w.reportlinker.com/p0164230/Hemoglobin-A1c-Monitor...ness of affliction and the need for effective ther... a significant market for monitoring the treatment...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Global Markets ...rtlinker.com/p0166826/Global-Markets-for-Asthma-an...ysis of the global market for medications that tre...e ,, Contains global market forecasts through 2...
(Date:12/2/2009)...ITTLE FALLS, N.J., Dec. 2 /PRNewswire-FirstCall/ -... the results for its first quarter ended October 3... hold a conference call to discuss the results at ...arles M. Diker, Chairman; Andrew A. Krakauer, Pres...dent; Craig A. Sheldon, Senior Vice President, CFO...
Breaking Medicine Technology:Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 2Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 3Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 5Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 6Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 2Reportlinker Adds Global Markets for Asthma and COPD Drugs 3Reportlinker Adds Global Markets for Asthma and COPD Drugs 4Reportlinker Adds Global Markets for Asthma and COPD Drugs 5Reportlinker Adds Global Markets for Asthma and COPD Drugs 6Reportlinker Adds Global Markets for Asthma and COPD Drugs 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 8Reportlinker Adds Global Markets for Asthma and COPD Drugs 9Reportlinker Adds Global Markets for Asthma and COPD Drugs 10Reportlinker Adds Global Markets for Asthma and COPD Drugs 11Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2New York Personal Injury Attorney Defends Medical Malpractice 55474 1New York Personal Injury Attorney Defends Medical Malpractice 55474 2New York Personal Injury Attorney Defends Medical Malpractice 55474 3Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 1Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 2Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 1Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 2Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 3Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 4Breakthrough Technology Harnesses Microorganism for Use as Green Bio Pesticide 55467 5
...Austria, June 11 /PRNewswire-FirstCall/,-- Iomai C...blication of data,from the company,s positive Phas...e in The Lancet. The study, which analyzed data fr... Iomai patch-based vaccine were,statistically sign...gnificant diarrhea than their counterparts who rec...
...U today,announced that its WaveReady 3000 series h... Inc. as compatible with Brocade-based Storage Are...esting requirements of the,Brocade Data Center Rea...to,foster interoperability in multi-vendor Brocade... that JDSU has successfully completed the Data Cen...
Other Medicine Technology:Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 2Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 4Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 5Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 7JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures 2JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures 3
Lawson Lite
High Lite Sport
KX-21N™ Automated Hematology Analyzer
...designed,for the rapid, qualitative detection of...nt throat specimens. The kit is,self-contained a... perform 25 or 50 tests including the throat swabs...,for the rapid, qualitative detection of Group A...
Medicine Products: